Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial - Lohmander, L S; Hellot, S; Dreher, D (Arthritis Rheumatol, 2014)